Chronic low-grade inflammation, characterized by elevated levels of pro-inflammatory cytokines such as IL-6 and TNF-α, plays a pivotal role in driving atherosclerosis and cardiovascular risk in T2DM patients [75]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.